• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Breaking News: Detroit Decriminalizes Psychedelics

Jason Najum by Jason Najum
November 4, 2021
in Breaking News
Reading Time: 2 mins read
A A
Breaking News: Detroit Decriminalizes Psychedelics

Last month it was Seattle becoming the biggest city in the US to decriminalize psychedelics. See our coverage here.

And now we have another major American city taking the historic step.

This week the citizens of Detroit voted to decriminalize psychedelics through a ballot initiative. By moving psychedelics to the city’s lowest law enforcement priority, ‘Proposal E’ makes the “personal possession and therapeutic use” of naturally occurring entheogenic plants and fungi by adults de facto decriminalized.  

https://www.instagram.com/p/CVzGC0xr7CW/?utm_source=ig_embed&ig_rid=8c0d773b-fb66-4bd8-a52c-7fbd66e627f1

[bsa_pro_ad_space id=2]
ADVERTISEMENT

61% of voters voted for the measure (39% voted against it), a very solid majority, showing how far the scrim movement has come. Highlighting this is the fact that Detroit requires direct ballot initiates by activists and citizens, rather than by city council votes, directly demonstrating that residents of the city were ready for this move.

Continue on your trip...

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Order Lasix Now

Here’s some of the wording from the approved measure: “voters of the City of Detroit [will] adopt an ordinance to the 2019 Detroit City Code that would decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of Entheogenic Plants by persons twenty-one (21) years of age and older, make the personal possession and therapeutic use of Entheogenic Plants by persons twenty-one (21) years of age and older the city’s lowest law-enforcement priority, and establish an entheogen policy review panel to assess and report on the effects of the ordinance.”

Decriminalize Nature Detroit was instrumental in the movement and is campaigning for statewide decriminalization of psychedelic substances in Michigan (possession, cultivation, and delivery of entheogenic plants, not for commercial uses). The bill is in committee review for public safety and is scheduled to be tabled for a vote next year.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post
Psychedelic Titans with Kimberly Juroviesky of Ketamine Taskforce INC

Psychedelic Titans with Kimberly Juroviesky of Ketamine Taskforce INC

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.